Back

Bi-atrial substrate characterization in cardiac amyloidosis: a comparative analysis of AL and ATTR forms and implications for ablation of atrial fibrillation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial substrate mapping Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jan Philipp Huisl

University hospital Giessen and Marburg, Giessen, Giessen (Germany)

6 More presentations in this session

Presentation thumbnail
Outcomes of atrial functional substrate mapping based ablation detected by isochronal late activation mapping in addition to pulmonary vein isolation in atrial fibrillation
Doctor C. Menemencioglu (Yozgat, TR)
Abstract Slides Video
Presentation thumbnail
Identification of the mapping-based voltage-derived parameter for accurate arrhythmia outcome prediction in patients undergoing first PVI
Doctor T. Huang (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Identification of low-voltage areas during atrial fibrillation: a unipolar, bipolar and omnipolar perspective
Assistant Professor M. Van Schie (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Endocardial low voltage areas have a significantly reduced success rate after ablation of persistent atrial fibrillation: a prospective randomized trial
Doctor B. Kaiser (Stuttgart, DE)
Abstract Slides Video
Presentation thumbnail
Dynamic left atrial substrate in patients undergoing redo ablation for atrial fibrillation recurrence
Doctor A. Spadotto (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial substrate mapping

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with cardiac amyloidosis - Clinical characteristics and outcomes
thumbnail
Congress Presentation
Management of arrhythmias in cardiac amyloidosis
thumbnail
Congress Presentation
CMR-derived left atrial strain predicts incident atrial fibrillation in transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources